Three molecular structures cause rhesus D category VI phenotypes with distinct immunohematologic features

被引:96
作者
Wagner, FF
Gassner, C
Müller, TH
Schönitzer, D
Schunter, F
Flegel, WA
机构
[1] Univ Ulm, Abt Transfus Med, D-89081 Ulm, Germany
[2] DRK Blutspendezent Ulm, Ulm, Germany
[3] Zent Inst Bluttranfus, Innsbruck, Austria
[4] Immunol Abt Innsbruck, Innsbruck, Austria
[5] Inst Oldenburg, Oldenburg, Germany
[6] DRK Blutspendedienst Niedersachsen Oldenburg, Oldenburg, Germany
关键词
D O I
10.1182/blood.V91.6.2157.2157_2157_2168
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rhesus D category VI (D-VI) is the clinically most important partial D, D-VI red blood cells were assumed to possess very low RhD antigen density and to be caused by two RHD-CE-D hybrid alleles, Because there was no population-based workup, we screened three populations in central Europe for D-VI. Twenty-six D-VI samples were detected and examined by exon-specific RHD polymerase chain reaction with sequence-specific primers (PCR-SSP). A new genotype, hereby designated D category VI type Ill, was characterized as a RHD-Ce(3-6)-D hybrid allele by sequencing of the cDNA, parts of intron 1, and by PCR-restriction fragment length polymorphism (PCR-RFLP) of intron 2. Rhesus introns 5 and 6 were sequenced and the 3' breakpoints of all known D-VI types shown to be distinct. We differentiated the 5' breakpoints of D-VI type land D-VI type II by a newly devised RHD-PCR. Thus, the D-VI phenotype originated in at least three independent molecular events. Each D-VI type showed distinct immunohematologic features in flow cytometry. The number of RhD proteins accessible on the red blood cells' surface of D-VI type III was normal(about 12,000 antigens/cell; D-VI type 1,500; D-VI type II, 2,400) based on the determination of an RhD epitope density profile. D-VI type II and D-VI type III occurred as CDe haplotypes, and D-VI type I as a cDE haplotype, The distribution of the D-VI types varied significantly in three German-speaking populations. Genotyping strategies should take account of allelic variations in partial RhD. The reconsideration of previous serologic and clinical data for partial D in view of the underlying molecular structures may be worthwhile, (C) 1998 by The American Society of Hematology.
引用
收藏
页码:2157 / 2168
页数:12
相关论文
共 68 条
[1]  
[Anonymous], 1984, The Human Blood Groups
[2]   QUANTITATIVE STUDIES ON THE RH-ANTIGEN-D - EFFECT OF THE C-GENE [J].
ARASZKIEWICZ, P ;
SZYMANSKI, IO .
TRANSFUSION, 1987, 27 (03) :257-261
[3]  
ARCE MA, 1993, BLOOD, V82, P651
[4]  
ARMSTRONGFISHER SS, 1996, TRANSFUS CLIN BIOL, V6, P505
[5]   CDNA CLONING OF A 30-KDA ERYTHROCYTE-MEMBRANE PROTEIN ASSOCIATED WITH RH (RHESUS)-BLOOD-GROUP-ANTIGEN EXPRESSION [J].
AVENT, ND ;
RIDGWELL, K ;
TANNER, MJA ;
ANSTEE, DJ .
BIOCHEMICAL JOURNAL, 1990, 271 (03) :821-825
[6]   Molecular basis of the D variant phenotypes DNU and D-II allows localization of critical amino acids required for expression of Rh D epitopes epD3, 4 and 9 to the sixth external domain of the Rh D protein [J].
Avent, ND ;
Jones, JW ;
Liu, W ;
Scott, ML ;
Voak, D ;
Flegel, WA ;
Wagner, FF ;
Green, C .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (02) :366-371
[7]   Molecular analysis of Rh transcripts and polypeptides from individuals expressing the D-VI variant phenotype: An RHD gene deletion event does not generate all D(VI)ccEe phenotypes [J].
Avent, ND ;
Liu, W ;
Jones, JW ;
Scott, ML ;
Voak, D ;
Pisacka, M ;
Watt, J ;
Fletcher, A .
BLOOD, 1997, 89 (05) :1779-1786
[8]   Evidence of genetic diversity underlying Rh D-, weak D (D-u), and partial D phenotypes as determined by multiplex polymerase chain reaction analysis of the RHD gene [J].
Avent, ND ;
Martin, PG ;
ArmstrongFisher, SS ;
Liu, W ;
Finning, KM ;
Maddocks, D ;
Urbaniak, SJ .
BLOOD, 1997, 89 (07) :2568-2577
[9]  
AVENT ND, 1992, J BIOL CHEM, V267, P15134
[10]  
AVENT ND, 1996, TRANSFUS CLIN BIOL, V6, P511